- Fexaramine
-
- $68.00
-
2026-07-27
- CAS:574013-66-4
- Purity: 99.12%
- Supply Ability: 10g
- Fexaramine
-
- $1.00
-
2019-09-06
- CAS:574013-66-4
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 20kg
|
| | Fexaramine Basic information |
| Product Name: | Fexaramine | | Synonyms: | Fexaramine;3-[3-[(Cyclohexylcarbonyl)[[4\'-(dimethylamino)[1,1\'-biphenyl]-4-yl]methyl]amino]phenyl]-2-Propenoic acid methyl ester, >98%;CS-1691;3-[3-[(Cyclohexylcarbonyl)-[[4'-(dimethylamino)-[1,1'-biphenyl]-4-yl]methyl]amino]phenyl]-2-propenoicacidmethylester;2-Propenoic acid, 3-[3-[(cyclohexylcarbonyl)[[4'-(diMethylaMino)[1,1'-biphenyl]-4-yl]Methyl]aMino]phenyl]-, Methyl ester;(E)-methyl 3-(3-(N-((4'-(dimethylamino)biphenyl-4-yl)methyl)cyclohexanecarboxamido)phenyl)acrylate;(2E,4Z)-5-(3-(N-((4'-(dimethylamino)biphenyl-4-yl)methyl)cyclohexanecarboxamido)phenyl)-4-(methoxycarbonyl)penta-2,4-dienoic acid;3-[3-[(Cyclohexylcarbonyl)-[[4'-(dimethylamino)-[1,1'-biphenyl]-4-yl]methyl]amino]phenyl]-2-pr | | CAS: | 574013-66-4 | | MF: | C32H36N2O3 | | MW: | 496.64 | | EINECS: | | | Product Categories: | Inhibitors | | Mol File: | 574013-66-4.mol |  |
| | Fexaramine Chemical Properties |
| Boiling point | 677.7±55.0 °C(Predicted) | | density | 1.158±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO : 50 mg/mL (100.68 mM; Need ultrasonic) | | form | powder | | pka | 4.95±0.24(Predicted) | | color | white to beige | | InChIKey | VLQTUNDJHLEFEQ-KGENOOAVSA-N | | SMILES | C(OC)(=O)/C=C/C1=CC=CC(N(C(C2CCCCC2)=O)CC2=CC=C(C3=CC=C(N(C)C)C=C3)C=C2)=C1 |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Acute Tox. 4 Oral
Aquatic Chronic 4 |
| | Fexaramine Usage And Synthesis |
| Description | The farnesoid X receptor (FXR) is a nuclear receptor that acts as a bile acid sensor, protecting cells and organs against bile acid toxicity and coordinating cholesterol metabolism, lipid homeostasis, and absorption of dietary fats and vitamins. Fexaramine is an FXR agonist (EC50 = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency compared to the high affinity FXR agonist GW 4064 (; EC50 = 80 nM). Fexaramine does not display activity at the following nuclear receptors: hRXRα, hPPARαγδ, mPXR, hPXR, hLXRα, hTRβ, hRARβ, mCAR, mERRγ, or hVDR. | | Uses | Fexaramine has been used to study its action on RANKL (receptor activator of nuclear factor-κB ligand)-induced osteoclastogenesis in mouse model. | | Definition | ChEBI: Fexaramine is a member of biphenyls. | | General Description | Fexaramine belongs to the nuclear hormone receptor family. | | Biological Activity | Potent, selective farnesoid X receptor agonist (EC 50 = 25 nM). Displays no activity at hRXR α , hPPAR α , hPPAR γ , hPPAR δ , mPXR, hPXR, hLXR α , hTR β , hRAR β , mCAR, mERR γ and hVDR receptors. | | Biochem/physiol Actions | Fexaramine might regulate lipid and glucose metabolism and can serve as a therapeutic target in the treatment of fatty liver disease, type 2 diabetes and obesity. Fexaramine might mediate cholesterol homeostasis and promotes osteoblast differentiation and suppresses differentiation of osteoclast. | | storage | Desiccate at +4°C | | References | [1] MICHAEL DOWNES. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR.[J]. Molecular Cell, 2003, 11 4: 1079-1092. DOI: 10.1016/s1097-2765(03)00104-7 |
| | Fexaramine Preparation Products And Raw materials |
|